Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
DiscussionThe present study was approved and conducted as an initiative study of the Japanese Association for Acute Medicine. If non-inferiority is identified, the society will pursue an application for the national health insurance coverage of levetiracetam for SE via a public knowledge-based application.Trial registrationJapan Registry of Clinical TrialsjRCTs031190160. Registered on December 13, 2019 (Source: Trials)
Source: Trials - May 2, 2021 Category: Research Source Type: clinical trials

DDI Study of ASC41 Tablets in HV and the PK, Safety and Tolerability in Subjects With NAFLD.
Conditions:   Healthy;   NAFLD Interventions:   Drug: ASC41;   Drug: Itraconazole;   Drug: Phenytoin Sponsor:   Gannex Pharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2021 Category: Research Source Type: clinical trials